ERBB2 and breast carcinoma: Furthermore, tumours arising in younger women have significantly lower ERα and PR expression, but higher HER-2 and EGFR expression [72], and in Basal-like breast cancers and breast tumours in younger women, the level and expression of EGFR is an adverse prognostic factor [72, 73].